Reich Kristian's Form 4 filing
MoonLake Immunotherapeutics (MLTX) · filed Feb 16, 2024
- Accession no.
- 0001213900-24-014996
- Filed
- Feb 16, 2024
- Trade date
- Feb 14-16, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.65M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reich KristianCIK 0001920553 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2024 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −10,000 | $62.42 | −$624,200 | 3,017,483 | Indirect | |
| Feb 14, 2024 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −10,000 | $62.43 | −$624,300 | 130,071 | Direct | |
| Feb 15, 2024 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −10,000 | $60.17 | −$601,700 | 3,007,483 | Indirect | |
| Feb 15, 2024 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −10,000 | $60.16 | −$601,600 | 120,071 | Direct | |
| Feb 16, 2024 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −10,000 | $60.15 | −$601,500 | 2,997,483 | Indirect | |
| Feb 16, 2024 | Class A ordinary shares, par value $0.0001 per share | SSaleDisposed | −10,000 | $60.15 | −$601,500 | 110,071 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.